Cryo AF Global Registry

Cryo AF Global Registry - Cryo AF Global Registry

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000025280

Enrollment

4500

Registered

2016-12-15

Start date

2017-02-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug refractory and reoccurrence symptomatic paroxysmal and persistent atrial fibrillation

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subject is over 18 years old of age Planned procedure using commercially available Arctic Front Cardiac Cryoablation Catheter Willing to comply with study requirements and give informed consent (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this clinical study) ot authorization per institution and geographical requirements

Exclusion criteria

Exclusion criteria: Subject is enrolled in a concurrent study that has not been approved for concurrent enrollment by the global study manager. Subject with exclusion criteria required by local law

Design outcomes

Primary

Measure	Time frame
1.Twelve-month freedom from atrial fibrillation (AF) recurrence 2.Twelve-month freedom from AF / Atrial Flutter (AFL)/Atrial Tachycardia (AT) recurrence 3.Device or procedure related adverse events for cryoablation through 12 months	—

Countries

Japan,Asia(except Japan),South America,Europe

Contacts

Public ContactTakashi Hamajima

Medtronic Japan Co., Ltd. Clinical and Medical Affairs OU Clinical Division 4

takashi.hamajima@medtronic.com070-1356-0767

Outcome results